Literature DB >> 23852787

Brief communication: comparison the diagnostic performance of four HBsAg ELISA kits.

Xu Wan-zhou1, Li Yan, Wu Qing, Wang Ming, Wu Ze-gang.   

Abstract

BACKGROUND: Comparison of diagnostic efficiency of four ELISA kits for determining HBsAg.
METHODS: Collecting 348 serum samples from clinical laboratory of Renmin Hospital of Wuhan University without specific gender and age requirements, determining HBsAg by the four ELISA kits, simultaneously. Confirmatory test was carried out when the initial results are positive.
RESULTS: 329 out of 348 samples results were consistent (94.5%), 152 out of 329 were positive, and 177 out of 329 were negative, and all the positive results can be confirmed; 19 samples were not consistent (5.5%), and only 1 sample was confirmed by the confirmatory test. After calculation, the diagnostic efficiencies of the four ELISA kits (Beijing Wantai, Xiamen Xinchuang, Zhuhai Lizhu, and Shanghai Kehua) were 98.6%, 98.0%, 99.7%, and 97.4%, respectively, the sensitivities were 100%, 99.4%, 99.4%, and 100%, respectively, the specificities were 97.5%, 96.9%, 100%, and 95.4%, respectively, the false positive rates were 2.5%, 3.1%, 0, and 4.6%, respectively, and the false negative rates were 0, 0.6%, 0.6%, and 0, respectively. All the initial absorbencies of the false positive samples were less than 1.0.
CONCLUSION: The diagnostic efficiency of Lizhu is the highest, while Kehua is the lowest. False positive or false negative results would take place in any of the kits, an HBsAg confirmatory test is essential for initially positive samples, especially with absorbance <1.0, because it can exclude most false positives.
© 2013 Wiley Periodicals, Inc.

Keywords:  ELISA; HBsAg; confirmatory test; diagnostic kit; diagnostic performance

Mesh:

Substances:

Year:  2013        PMID: 23852787      PMCID: PMC6807336          DOI: 10.1002/jcla.21600

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  8 in total

1.  Hepatitis B surface antigen: decreased need for confirmation of reactive results.

Authors:  J E O'Brien
Journal:  Clin Chem       Date:  2000-04       Impact factor: 8.327

Review 2.  Hepatitis B virus infection--natural history and clinical consequences.

Authors:  Don Ganem; Alfred M Prince
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

Review 3.  Clinical practice: prevention of hepatitis B with the hepatitis B vaccine.

Authors:  Gregory A Poland; Robert M Jacobson
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

4.  Evaluation of two chemiluminescent immunoassays of ADVIA Centaur for hepatitis B serology markers.

Authors:  Dan Chen; Lawrence Kaplan; Qiang Liu
Journal:  Clin Chim Acta       Date:  2005-05       Impact factor: 3.786

5.  Comparison of the results for three automated immunoassay systems in determining serum HBV markers.

Authors:  Yu Chen; Wei Wu; Lan-juan Li; Bin Lou; Jie Zhang; Jian Fan
Journal:  Clin Chim Acta       Date:  2006-05-19       Impact factor: 3.786

6.  Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers.

Authors:  Philippe Colson; Patrick Borentain; Anne Motte; Mireille Henry; Valérie Moal; Danielle Botta-Fridlund; Catherine Tamalet; René Gérolami
Journal:  Virology       Date:  2007-06-18       Impact factor: 3.616

7.  Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.

Authors:  B J McMahon; W L Alward; D B Hall; W L Heyward; T R Bender; D P Francis; J E Maynard
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

Review 8.  [Serum biological markers and screening of viral hepatitis].

Authors:  C Buffet
Journal:  Rev Prat       Date:  1995-01-15
  8 in total
  4 in total

1.  Analytical performance of three diagnostic reagents for HBsAg on an automatic ELISA analyzer.

Authors:  Jiayi Hou; Jianping Ren; Ling Song; Fen Zhao; Peijun Liang
Journal:  J Clin Lab Anal       Date:  2017-02-10       Impact factor: 2.352

Review 2.  Viral Biomarkers in Chronic HBeAg Negative HBV Infection.

Authors:  Emilia Hadziyannis; Andreas Laras
Journal:  Genes (Basel)       Date:  2018-09-27       Impact factor: 4.096

Review 3.  Microfluidic biosensing systems using magnetic nanoparticles.

Authors:  Ioanna Giouroudi; Franz Keplinger
Journal:  Int J Mol Sci       Date:  2013-09-09       Impact factor: 5.923

4.  Preliminary Assessment of Various Additives on the Specific Reactivity of Anti- rHBsAg Monoclonal Antibodies.

Authors:  Yaghoub Yazdani; Saeed Mohammadi; Mehdi Yousefi; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2015 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.